HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 22, Issue 1, Pages 33-52 (February 2008)


View previous. 7 of 17 View next.

The Clinical Spectrum of Antiphospholipid Syndrome

William F. Baker Jr., MD, FACPabcCorresponding Author Informationemail address, Rodger L. Bick, MD, PhD, FACPd

Antiphospholipid syndrome (APS) is a disorder characterized by a wide variety of clinical manifestations. Virtually any organ system or tissue may be affected by the consequences of large- or small-vessel thrombosis. There is a broad spectrum of disease among individuals with antiphospholipid antibodies (aPL). Patients may exhibit clinical features suggesting APS but not fulfill the International Criteria for a “definite” diagnosis. Seronegative APS patients demonstrate typical idiopathic thromboses but aPL are not initially detected. Patients defined with definite APS demonstrate nearly identical sites of venous and arterial thrombosis, regardless of the presence or absence of systemic lupus erythematosus. Microangiopathic APS may present with isolated tissue and organ injury or as the overwhelming “thrombotic storm” observed in catastrophic APS.

a David Geffen School of Medicine, Center for Health Sciences, University of California, Los Angeles, Los Angeles, CA, USA

b California Clinical Thrombosis Center, 9330 Stockdale Highway, Suite 300, Bakersfield, CA 93311, USA

c Thrombosis, Hemostasis and Special Hamatology Clinic, Kern Medical Center, Bakersfield, CA 93305, USA

d 10455 North Central Expressway, Suite 109-320, Dallas, TX 75231, USA

Corresponding Author InformationCorresponding author.

PII: S0889-8588(07)00170-0

doi:10.1016/j.hoc.2007.10.007


View previous. 7 of 17 View next.